<DOC>
	<DOCNO>NCT00974025</DOCNO>
	<brief_summary>In study , investigator evaluate effect vitamin C endothelial function , exercise tolerance quality life patient single ventricle palliate Fontan physiology . The hypothesis vitamin C result improve exercise tolerance endothelial function patient undergone Fontan operation , compare placebo .</brief_summary>
	<brief_title>Impact Vitamin C Endothelial Function Exercise Capacity Fontan-Palliated Patients</brief_title>
	<detailed_description>Recent evidence suggest Fontan operation , single ventricle patient impaired function vascular endothelium due part abnormality nitric oxide signal . Endothelial dysfunction may contribute development congestive heart failure exercise intolerance well-documented Fontan patient . Therapeutic intervention improve endothelial function adult heart failure mainly focus increase synthesis decrease degradation nitric oxide . We propose randomize , prospective , placebo-controlled trial vitamin C , antioxidant protect NO deactivation , subject single ventricular anatomy Fontan palliation . The specific aim study compare NO signaling , endothelial function exercise capacity Fontan subject control group frequency-matched case subject age sex , assess NO signaling , endothelial function exercise capacity Fontan subject 4 week oral vitamin C ( placebo ) therapy . These result particular importance improve endothelial response Fontan patient potential reduce risk develop congestive heart failure improve exercise capacity . Furthermore , assess endothelial function effect therapy aim improve vascular health may generalizable many chronic pediatric condition associate increase cardiovascular risk obesity , diabetes mellitus , hypertension .</detailed_description>
	<mesh_term>Tricuspid Atresia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>825 year age Fontanpalliated patient New York Heart Association ( NYHA ) class III IV Diabetes mellitus Family history premature coronary artery disease Use Sildenafil pulmonary artery vasodilator Prior cardiac arrest ( outside first 24hours postoperatively ) Lifethreatening dysrhythmias Severe ventricular dysfunction Severe AV valve regurgitation Pregnancy Severe renal hepatic impairment</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>